Intrinsic Value of S&P & Nasdaq Contact Us

ALX Oncology Holdings Inc. ALXO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+147.7%

Stock Statistics — ALXO

ALX Oncology Holdings Inc. (ALXO) has a market capitalization of $87.58M and trades at $1.62. The 52-week range is 0.404-2.66.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.90.

The stock has a beta of 0.50, operates in the Healthcare sector.

Trading Data
Current Price$1.62
52-Week Range0.404-2.66
Volume651.8K
Avg Volume (30D)827.04K
Market Cap$87.58M
Beta (1Y)0.50
Company
IPO Date2020-07-17
Employees65
CEOJason W. Lettmann
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS00166B1052
CUSIP00166B105
Income (Latest Year)
EBITDA$-100.85M
Operating Income$-100.85M
Net Income$-101.7M
EPS$-1.90
EPS Diluted$-1.90
Shares Outstanding$53.66M
Balance Sheet (Latest Year)
Total Assets$59.05M
Current Assets$50.73M
Cash & ST Investments$44.79M
Total Liabilities$33.07M
Total Debt$5.22M
Net Debt$-11.16M
Total Equity$25.98M
Debt / Equity0.20
Valuation Ratios
P/E Ratio-0.9
P/B Ratio3.37
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message